semaglutide for fertility Injectable shows promise improving in women with PMOS Ozempic Babies: Weight Loss Drugs,

My GLP lecture here To view or add a comment, sign in MHRA approves olezarsen (Tryngolza) for the treatment of familial chylomicronemia syndrome Published at 10 April 2026 The Medicines and Healthcare products Regulatory Agency (MHRA) has today 10 April 2026, approved olezarsen (Tryngolza) to help treat adults with familial chylomicronemia syndrome (FCS)

The ADA recommends HbA1c monitoring every 3 months until targets are achieved, then every 6 months

But the fact that for those of us who watch baseball, I dont watch it near as much as I used to when I was a kid, but the fact that its faster makes it a ton better

This genetic map guides your provider to personalize your medication and expected response, rather than using one-size-fits-all dosing protocols

10 providers ranked by cost

Research shows that 30-40% of GLP-1 users hit a weight-loss plateau within the first 6-12 months, but this does not mean the medication has failedit often signals that your body and treatment plan need recalibration